Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase

Bone Marrow Transplantation

Volumn 20, Issue 11, 1997, Pages 945-952

  Gallardo, D ^a   Garcia Lopez J ^a   Sureda, A ^b   Canals, C ^a   Ferra, C ^a   Cancelas, J A ^a   Berlanga, J J ^a   Brunet, S ^b   Boque C ^a   Picon M ^a   Torrico, C ^a   Amill, B ^a   Martino, R ^b   Martinez C ^a   Martin Henao G ^a   Domingo Albos A ^b   Granena A ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

CD8+ lymphocytes; Graft failure; GVHD prevention; T cell subset depletion

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; HLA DR ANTIGEN; METHOTREXATE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CELL SEPARATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; LYMPHOCYTOSIS; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 1842292199     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701008     Document Type: Article

References (41)

1. Storb R, Deeg HG, Pepe M et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood 1989; 73: 1729-1734.
2. de Witte T, Hoogenhout J, de Pauw B et al. Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation. Blood 1986; 67: 1302-1308.
3. Antin HJ, Bierer BE, Smith BR et al. Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematological malignancies. Blood 1991; 78: 2139-2149.
4. Marmont AM, Horowitz MM, Gale RP et al. T cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-2130.
5. Przepiorka D, Gonzales-Chambers R, Winkelstein A et al. Chimerism studies using in situ hybridisation for the Y chromosome after T cell depleted bone marrow transplantation. Bone Marrow Transplant 1990; 5: 253-257.
6. Roux E, Helg C, Dumont-Girard F et al. Analysis of T cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T cell depleted and unmanipulated grafts. Blood 1996; 87: 3984-3992.
7. Martin PJ, Hansen JA, Buckner CD et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985; 66: 664-672.
8. Butturini A, Gale RP. T cell depletion in bone marrow transplantation for leukemia: current results and future directions. Bone Marrow Transplant 1988; 3: 265-279.
9. Drobyski WR, Ash RC, Casper JT et al. Effect of T cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 1980-1987.
10. Champlin R. T cell depletion for allogeneic bone marrow transplantation: impact on graft-versus-host disease, engraftment and graft-versus-leukemia. J Hematother 1993; 2: 27-42.
11. + thymocytes. Blood 1992; 80: 2406-2411.
12. + T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation. Transplantation 1995; 60: 355-361.
13. Martin PJ. The role of donor lymphoid cells in allogeneic marrow engraftment. Bone Marrow Transplant 1990; 6: 283-289.
14. + cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow. Bone Marrow Transplant 1991; 8: 51-58.
15. Korngold R, Sprent J. T cell subsets and graft-versus-host diseas. Transplantation 1987; 44: 335-339.
16. Champlin RE, Jansen J, Ho W et al. Retention of graft-versus-leukemia using selective depletion of CD8-positive lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia. Transplant Proc 1991; 23: 1695-1696.
17. Nimer S, Giorgi J, Gajewski J et al. Selective depletion of CD8-positive cells for prevention of graft-versus-host disease following bone marrow transplantation: a randomized controlled trial. Transplantation 1994; 57: 82-87.
18. + T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood 1990; 76: 418-423.
19. Jansen J, Hanks S, Akard L et al. Selective T cell depletion with CD8-conjugated magnetic heads in the prevention of graft-versus-host disease after allogeneic hone marrow transplantation. Bone Marrow Transplant 1995; 15: 271-278.
20. + cell depletion for patients at high risk for severe acute GVHD. Bone Marrow Transplant 1996; 17: 377-382.
21. Martin PJ. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J Exp Med 1993; 178: 703-712.
22. Verdonck LF, de Gast GC, van Heugten HG, Dekker AW. A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation. Blood 1990; 75: 776-780.
23. Verdonck LF, Dekker AW, de Gast GC et al. Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood 1994; 83: 3090-3096.
24. Grañena A, Canals C, Picon M et al. GVHD prophylaxis in CML: complete depletion of CD4 cells and controlled numbers of CD8 lymphocytes in the donor BM. Bone Marrow Transplant 1994; 14 (Suppl. 3): S85.
25. Canals C, Picon M, Torrico C et al. GVHD prophylaxis in CML: complete depletion of CD4 cells and controlled numbers of CD8 lymphocytes in the donor BM. Exp Hematol 1994; 22: 695 (Abstr. 70).
26. Ringden O, Nilsson B. Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose and splenectomy. Transplantation 1985;40: 39-44
27. Gale RP, Bortin MM, van Bekkum DW et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987; 67: 397-406.
28. Nash RA, Pepe MS, Storb R et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80: 1838-1845.
29. Przepiorka D, Weisdorf D, Martin P et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
30. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
31. Goulmy E, Schipper R, Pool J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. New Engl J Med 1996; 334: 281-285.
32. Martin PJ. Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism. Blood 1996; 88: 962-969.
33. Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chonic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T cell depletion. Ann Intern Med 1988; 108: 806-814.
34. Apperley J, Jones L, Hale G et al. Bone marrow transplantation for patients with chronic myeloid leukemia: T cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukemic relapse. Bone Marrow Transplant 1986; 1: 53-66.
35. Keever CA, Small TN, Flomenberg N et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T cell-depleted marrow with recipients of conventional marrow grafts. Blood 1989; 73: 1340-1350.
36. Soiffer RJ, Bosserman L, Murray C et al. Reconstitution of T cell function after CD6-depleted allogeneic bone marrow transplantation. Blood 1990; 75: 2076-2084.
37. Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5: 209-226.
38. - T cells repopulate at different rates after allogeneic bone marrow transplantation. Bone Marrow Transplant 1989; 4: 291-296.
39. + dual-positive T cells reminiscent of ontogeny. J Hematother 1992; 1: 303-316.
40. + natural killer cells after bone marrow transplantation. Blood 1992; 79: 3239-3244.
41. Storek J, Saxon A. Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant 1992; 9: 395-408.